Free Trial

Marker Therapeutics (MRKR) Earnings Date, Estimates & Call Transcripts

Marker Therapeutics logo
$3.66
-0.39 (-9.63%)
(As of 11/1/2024 ET)

Marker Therapeutics Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 14Estimated
Actual EPS
(Aug. 14)
-$0.25 Missed By -$0.25

Marker Therapeutics posted Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.25. Quarterly revenue was reported to be $1.17 million. With a trailing EPS of $0.00, Marker Therapeutics' earnings are expected to decrease next year, from ($1.43) to ($1.46) per share.

MRKR Upcoming Earnings

Marker Therapeutics' next earnings date is estimated for Thursday, November 14, 2024, based off prior year's reporting schedules.

Get Marker Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Marker Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

MRKR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MRKR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Marker Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($1.43) EPS
Next Year EPS Consensus Estimate: ($1.46) EPS

Marker Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/14/2024
(Estimated)
------- 
8/14/2024Q2 2024--$0.25 -$0.25-$0.25-$1.17M
5/15/2024Q1 2024--$0.27 -$0.27-$0.27-$1.24M
11/9/2023Q3 2023--$0.34 -$0.34-$0.34-$0.26M
8/14/2023Q2 2023--$0.47 -$0.47-$1.23-$0.76M
5/16/2023Q1 2023--$0.57 -$0.57-$0.57-$4.73M
11/10/2022Q3 2022-$0.13-$0.08+$0.05-$0.08$0.80M$3.95M

Marker Therapeutics Earnings - Frequently Asked Questions

Marker Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on MRKR's earnings history.

Marker Therapeutics (NASDAQ:MRKR) has a recorded annual revenue of $3.31 million.

Marker Therapeutics (NASDAQ:MRKR) has a recorded net income of -$8.24 million. MRKR has generated $0.00 earnings per share over the last four quarters.

Marker Therapeutics's earnings are expected to decrease from ($1.43) per share to ($1.46) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:MRKR) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners